Will Neuroimaging Produce a Clinical Tool for Psychiatry?

The increasing incidence, awareness, and social and economic impact of mental health disorders, the current status quo of treatment options and their limited success, and the extensive investment into brain imaging research raises an important question for the future behavioral medicine: will neuroimaging produce a clinical tool for psychiatry? Significant advances in neuroimaging over the past two decades allow psychiatric clinicians to peer into the living, functioning brain. Neuroimaging has been used to diagnose mental illnesses, to predict treatment outcomes, to find new stratifications of psychiatric disorders, and to provide therapy. The development of computational techniques, alongside several population neuroimaging efforts worldwide, increase the prospect for a first neuroimaging-based clinical tool. In this article, we describe the formidable challenges to creating such a tool and forecast how current institutions can solve them through social, technical, educational, and policy changes, improving data sharing practices, advances in technology, and integration between neuroimaging and other emerging information streams.

[1]  Dick J. Veltman,et al.  Evaluating the evidence for biotypes of depression: attempted replication of Drysdale et.al. 2017 , 2018, bioRxiv.

[2]  M. Treadway,et al.  Anhedonia in depression: biological mechanisms and computational models , 2018, Current Opinion in Behavioral Sciences.

[3]  Janaina Mourão-Miranda,et al.  Making Individual Prognoses in Psychiatry Using Neuroimaging and Machine Learning. , 2018, Biological psychiatry. Cognitive neuroscience and neuroimaging.

[4]  Max W. Y. Lam,et al.  The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project , 2017, Schizophrenia Research.

[5]  B. Mwangi,et al.  The impact of machine learning techniques in the study of bipolar disorder: A systematic review , 2017, Neuroscience & Biobehavioral Reviews.

[6]  Dina R. Dajani,et al.  Progress and roadblocks in the search for brain-based biomarkers of autism and attention-deficit/hyperactivity disorder , 2017, Translational Psychiatry.

[7]  Michael C Neale,et al.  The ABCD Study of Neurodevelopment: Identifying Neurocircuit Targets for Prevention and Treatment of Adolescent Substance Abuse , 2017, Current Treatment Options in Psychiatry.

[8]  Jerzy Bodurka,et al.  Randomized Clinical Trial of Real-Time fMRI Amygdala Neurofeedback for Major Depressive Disorder: Effects on Symptoms and Autobiographical Memory Recall. , 2017, The American journal of psychiatry.

[9]  Andrew T. Drysdale,et al.  Resting-state connectivity biomarkers define neurophysiological subtypes of depression , 2016, Nature Medicine.

[10]  J D E Gabrieli,et al.  Brain connectomics predict response to treatment in social anxiety disorder , 2016, Molecular Psychiatry.

[11]  Lauren E. Ethridge,et al.  Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers. , 2016, The American journal of psychiatry.

[12]  H. Aizenstein,et al.  Studying depression using imaging and machine learning methods , 2015, NeuroImage: Clinical.

[13]  B. Kaplan,et al.  The Emerging Field of Nutritional Mental Health , 2015 .

[14]  Satrajit S. Ghosh,et al.  Prediction as a Humanitarian and Pragmatic Contribution from Human Cognitive Neuroscience , 2015, Neuron.

[15]  P. Wighton,et al.  Optimizing real time fMRI neurofeedback for therapeutic discovery and development , 2014, NeuroImage: Clinical.

[16]  Daniel P. Kennedy,et al.  The Autism Brain Imaging Data Exchange: Towards Large-Scale Evaluation of the Intrinsic Brain Architecture in Autism , 2013, Molecular Psychiatry.

[17]  Thomas E. Nichols,et al.  The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data , 2014, Brain Imaging and Behavior.

[18]  S. Lawrie,et al.  Towards the identification of imaging biomarkers in schizophrenia, using multivariate pattern classification at a single-subject level , 2013, NeuroImage: Clinical.

[19]  Satrajit S. Ghosh,et al.  Predicting treatment response in social anxiety disorder from functional magnetic resonance imaging. , 2012, JAMA psychiatry.

[20]  Jun Liu,et al.  Anatomical Brain Images Alone Can Accurately Diagnose Chronic Neuropsychiatric Illnesses , 2012, PloS one.

[21]  T. Insel,et al.  Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? , 2012, Molecular Psychiatry.

[22]  J. Mundt,et al.  Vocal Acoustic Biomarkers of Depression Severity and Treatment Response , 2012, Biological Psychiatry.

[23]  M. Milham,et al.  The ADHD-200 Consortium: A Model to Advance the Translational Potential of Neuroimaging in Clinical Neuroscience , 2012, Front. Syst. Neurosci..

[24]  M. Lemke,et al.  Spatiotemporal gait patterns during over ground locomotion in major depression compared with healthy controls. , 2000, Journal of psychiatric research.

[25]  D. Mitchell Wilkes,et al.  Acoustical properties of speech as indicators of depression and suicidal risk , 2000, IEEE Transactions on Biomedical Engineering.

[26]  A R Damasio,et al.  Gait disturbances in patients with autistic behavior: a preliminary study. , 1981, Archives of neurology.